Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
H5N1 antigen + AS03A
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
H5N1 antigen + AS03A is an investigational, egg-based, inactivated, monovalent split-virion influenza A (H5N1) vaccine adjuvanted with AS03A. AS03A is a full-dose formulation of the AS03 adjuvant system, which is an α-tocopherol-containing oil-in-water emulsion designed to enhance the immune response to the vaccine antigen. Developed and sponsored by the Biomedical Advanced Research and Development Authority (BARDA), this vaccine is intended for pandemic preparedness against avian influenza A (H5N1). The active component is the H5N1 influenza hemagglutinin (HA) antigen, which is being tested at various dose levels (3.75, 7.5, and 15 μg) to evaluate safety and immunogenicity in healthy adults.
- Other names
- A/H5 inactivated monovalent influenza vaccine adjuvanted with AS03H5N1 influenza vaccine + AS03Ainactivated monovalent influenza A (H5N1) vaccine adjuvanted with AS03A
02
Targets
H5 HA (Influenza A hemagglutinin H5)
Beyond the preview
Go deeper on H5N1 antigen + AS03A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H5N1 antigen + AS03A.